Aditya Birla Sun Life Pharma & Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

₹1,103 Cr

Lock In Period

N/A

Expense Ratio

2.27

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Benchmark

BSE Healthcare Total Return

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-0.85-0.273.85
6M16.013.3427.30
1Y16.204.9229.26
3Y20.3614.0193.51

Portfolio Analysis

  • Equity: 97.63%
  • Debt: 2.39%
  • Others
As on: 2026-07-31
View allocation % by

1. Torrent Pharmaceuticals Ltd.9.94%
2. Sun Pharmaceutical Industries Ltd.9.75%
3. Cipla Ltd.4.56%
4. Aurobindo Pharma Ltd.4.29%
5. Ajanta Pharma Ltd.4.17%
6. Sai Life Sciences Ltd.3.89%
7. Mankind Pharma Ltd.3.58%
8. Lupin Ltd.3.51%
9. Abbott India Ltd.3.35%
10. Emcure Pharmaceuticals Ltd.3.24%
11. IPCA Laboratories Ltd.2.47%
12. Gland Pharma Ltd.2.34%
13. Shilpa Medicare Ltd.2.32%
14. Corona Remedies Ltd.2.29%
15. Procter & Gamble Health Ltd.2.16%
16. Divi's Laboratories Ltd.1.95%
17. Alkem Laboratories Ltd.1.88%
18. Pfizer Ltd.1.26%
19. Biocon Ltd.1.26%
20. Piramal Pharma Ltd.1.16%
21. Anthem Biosciences Ltd.1.07%
22. Dr. Reddy's Laboratories Ltd.1.06%
23. Glaxosmithkline Pharmaceuticals Ltd.0.80%
24. Syngene International Ltd.0.68%
25. Jubilant Pharmova Ltd.0.55%

1. Apollo Hospitals Enterprise Ltd.7.08%
2. Fortis Healthcare Ltd.2.98%
3. Dr. Lal Path labs Ltd.2.12%
4. Jupiter Life Line Hospitals Ltd.2.03%
5. Thyrocare Technologies Ltd.1.91%
6. Metropolis Healthcare Ltd.1.59%
7. Vijaya Diagnostic Centre Ltd.0.98%
8. Manipal Health Enterprises Ltd A0.89%
9. Suraksha Diagnostic Ltd.0.79%
10. Max Healthcare Institute Ltd.0.72%

1. Sanofi Consumer Healthcare India Ltd.1.36%
No Data Found
No Data Found

About Fund Aditya Birla Sun Life Pharma & Healthcare Fund Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,103 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.27. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dhaval Shah

Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
Quant Healthcare Fund Growth0428 CR3.14
DSP Healthcare Fund Growth33,639 CR2.02
Aditya Birla Sun Life Pharma & Healthcare Fund Growth21,102 CR2.27
UTI Healthcare Fund Growth31,370 CR2.22
SBI Healthcare Opportunities Fund Growth35,399 CR2
Fund Name1Y3Y
This FundQuant Healthcare Fund Growth18.487769.261
This FundDSP Healthcare Fund Growth15.110273.9429
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth16.198174.3528
This FundUTI Healthcare Fund Growth16.163187.0405
This FundSBI Healthcare Opportunities Fund Growth20.911587.5881

Aditya Birla Sun Life Pharma & Healthcare Fund Growth FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.27. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -0.85%
  • 6 Months : 16.01%
  • 1 Year : 16.20%
  • 3 Years : 20.36%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 36.32 as on Sep 11,2026. Since inception, the return has been 74.35%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹1,103 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.